As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

  5/4/22  Allogene Therapeutics, Inc.       10-Q        3/31/22   59:5.9M                                                            
  4/4/22  PF Equity Holdings 2 B.V.         4          10% Owner²  1:4K   Allogene Therapeutics, Inc.                                
 3/31/22  Belldegrun Arie                   4          Director²   1:7K   Allogene Therapeutics, Inc.       Securex Filings/FA       

____________
¹	Filing/Form Types:
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	10-Q	Quarterly Report — Form 10-Q.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.